Business Context and Reporting Period
Company: Inmune Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 10, 2021
Reporting Period: Single event date (August 10, 2021)
Business Context: The Company is an emerging growth company incorporated in Nevada, with principal executive offices in Boca Raton, Florida. Its common stock trades on The NASDAQ Stock Market LLC under the symbol "INMB".
Key Financial Metrics
This filing is a Current Report (Form 8-K) regarding a corporate event and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
No material financial changes or operational updates were reported in this filing. The report solely discloses a scheduled corporate presentation.
Guidance, Outlook, and Management Commentary
Management Event: On August 10, 2021, the Company announced that Raymond J. Tesi, President and CEO, will present at the Canaccord Genuity 41st Annual Growth Conference.
Event Dates: August 10-12, 2021.
Exhibits: A press release regarding this event is filed as Exhibit 99.1.
Risks and Contingencies: No specific risks or contingencies were disclosed in this filing.
Key Facts for Investor Verification
- Verify the content of the press release filed as Exhibit 99.1 for details on the CEO's presentation.
- Confirm the schedule for the Canaccord Genuity 41st Annual Growth Conference (August 10-12, 2021).
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial performance.